Ildstad Suzanne's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Jun 9, 2023
- Accession no.
- 0001209191-23-035984
- Filed
- Jun 9, 2023
- Trade date
- Jun 7-9, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $342.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ildstad SuzanneCIK 0001845822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 | Common Stock | SSaleDisposed | −75,001 | $2.39 | −$179,252.39 | 3,881,473 | Direct | |
| Jun 8, 2023 | Common Stock | SSaleDisposed | −40,642 | $2.48 | −$100,792.16 | 3,840,831 | Direct | |
| Jun 9, 2023 | Common Stock | SSaleDisposed | −25,419 | $2.46 | −$62,530.74 | 3,815,412 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.